Neonatal Screening for Congenital Metabolic and Endocrine Di…

Established

42
Citations
33
Refs
2021
Year
Search Works
Work Details
  • DOI 10.3238/arztebl.m2021.0009
  • PMID https://pubmed.ncbi.nlm.nih.gov/33835005
  • OpenAlex ID W3119137315
  • Type Article
  • Language DE
  • Published 10 Feb 2021
  • Volume 118 (7)
  • Pages 101–108
  • Source Deutsches Ärzteblatt international
  • Publisher Deutscher Ärzte-Verlag
  • FWCI 5.31
  • Countries 2
  • Institutions 5
  • Added 18 Jan 2021
  • Updated 22 Oct 2026
External Links
OpenAlex Record DOI Resolver PubMed Open Access
MENU
0

Neonatal Screening for Congenital Metabolic and Endocrine Disorders

Article 2021 DE Green

BACKGROUND: The purpose of neonatal screening is the early detection of congenital metabolic and endocrine disorders that, if untreated, could lead to fatal crises or other long-term adverse sequelae. In Germany, neonatal screening is legally regulated. Quality-assurance reports ("DGNS reports") are created and published annually by the German Society for Neonatal Screening (Deutsche Gesellschaft…

42

Citations

33

References

7

Authors

5.31

FWCI

Citations by Year
Last 6 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
7 authors
#AuthorInstitutionsORCID
1 Anja Lüders University of Toronto (CA) Hospital for Sick Children (CA) +3 —
2 Oliver Blankenstein —
3 Inken Brockow —
4 Regina E. Ensenauer —
5 Martin S. Lindner —
6 Andreas Schulze —
7 Uta Nennstiel —
Related Works
10

Data: OpenAlex